QualityStocksNewsBreaks Archives - Page 22 of 1540

TuesdayMar 24, 2026 9:30 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) To Present Deciparticle Platform And Pipeline At BIO-Europe Spring 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present its Deciparticle (TM) nanomedicine platform and clinical pipeline at BIO-Europe Spring 2026 on March 25, where it has been selected as a presenting company. The company will highlight its next-generation drug delivery technology along with two lead candidates, Sapu003 (Everolimus for Injection), currently in Phase 1 trials, and Sapu006 (Docetaxel for Injection), entering Phase 1, as it seeks strategic partnerships to advance development and commercialization. To view the full press release, visit https://ibn.fm/Slq47 About Sapu Nano Sapu Nano is a biotechnology company developing next-generation nanomedicine platforms to improve drug…

MondayMar 23, 2026 2:57 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advances Orphan Drug Strategy With HyBryte In Rare Skin Cancer

Soligenix (NASDAQ: SNGX) is advancing a differentiated approach to orphan drug development, emphasizing a de-risked model focused on patient safety and capital efficiency, as highlighted in a recent citybiz feature. The company’s lead candidate, HyBryte(TM), targets cutaneous T-cell lymphoma using visible light activation rather than traditional chemotherapy or UV-based therapies, with clinical data indicating faster response times and a favorable safety profile, while also supporting potential at-home treatment through telehealth-enabled delivery. The company is nearing completion of a confirmatory Phase 3 study for HyBryte(TM), with interim analysis expected in early 2026 and top-line results later in the year, alongside supportive data showing strong patient response rates. Soligenix’s broader strategy leverages regulatory incentives for…

MondayMar 23, 2026 1:21 pm

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Prices $4 Million Registered Direct Offering

ParaZero Technologies (NASDAQ: PRZO) announced it has entered into a definitive agreement for a registered direct offering with a single institutional investor expected to generate approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares (or pre-funded warrants) at $0.75 per share. The company said proceeds will be used for general corporate purposes and working capital, with the transaction expected to close on or about March 24, 2026, and Aegis Capital Corp. acting as exclusive placement agent. To view the full press release, visit https://ibn.fm/8Z2ue About ParaZero Technologies ParaZero Technologies Ltd. (Nasdaq: PRZO) is an aerospace defense company pioneering smart, autonomous solutions for…

MondayMar 23, 2026 1:04 pm

QualityStocksNewsBreaks – OptimumBank Holdings, Inc. (NYSE American: OPHC) Ranked No. 49 Among Top 100 U.S. Community Banks By S&P Global

OptimumBank Holdings (NYSE American: OPHC) announced it has been ranked No. 49 in the S&P Global Market Intelligence 2025 Top 100 Best-Performing U.S. Community Banks under $3 billion in assets, placing it among the top 1.4% of 3,465 eligible institutions and as the only Florida-based bank included in the ranking. The recognition, based on metrics including profitability, growth, efficiency, asset quality and capitalization, reflects the bank’s strong financial performance and disciplined approach, with management also invited to share insights as one of two institutions selected for a national S&P webinar on top-performing banks. To view the full press release, visit https://ibn.fm/aoqIe About OptimumBank Holdings, Inc. Founded in…

MondayMar 23, 2026 12:55 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting

Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell lymphoma will be presented at the United States Cutaneous Lymphoma Consortium Workshop on March 26, 2026, ahead of the American Academy of Dermatology Annual Meeting. The presentations will highlight positive results from a long-term treatment study and a comparative analysis versus Valchlor(R), supporting HyBryte(TM) potential as a therapeutic option for CTCL. To view the full press release, visit https://ibn.fm/W9RAl About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte(TM) (SGX301…

MondayMar 23, 2026 12:39 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Provides Update On Murdock Mountain Drilling Timeline

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) reported a delay in its planned drilling program at the Murdock Mountain phosphate project due to incomplete environmental pre-clearance surveys required by the Bureau of Land Management and Nevada Department of Wildlife, and has engaged an additional environmental consulting firm to accelerate completion of the work. The company is also finalizing an agreement with a second drilling contractor to mitigate scheduling impacts and enable drilling to commence as soon as regulatory approvals are secured. To view the full press release, visit https://ibn.fm/LGPsl Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) NOP is…

MondayMar 23, 2026 12:22 pm

QualityStocksNewsBreaks – McEwen Inc. (NYSE: MUX) (TSX: MUX) Reports Tartan Mine Resource Estimate With Over 600,000 Gold Ounces

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising. McEwen (NYSE: MUX) (TSX: MUX) reported a mineral resource estimate for its Tartan Mine Project in Manitoba totaling 308,900 indicated gold ounces and 302,700 inferred gold ounces, with additional upside potential through further drilling across multiple zones and adjacent properties. The company said the project supports its goal of reaching 250,000 to 300,000 ounces of annual production by 2030, with initial output at Tartan expected to average approximately 30,000 ounces per year and potential expansion to 45,000 to 55,000 ounces annually through increased mill capacity, alongside ongoing exploration, metallurgical testing and mine planning initiatives. To view the full press release, visit, https://ibn.fm/KYiHz…

MondayMar 23, 2026 9:55 am

QualityStocksNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Appoints Britt Tucker Strategic Advisor

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising. Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced the appointment of Britt Tucker as a strategic advisor, bringing experience in global sales, business development and partnerships across the commercial space sector. In her role, Tucker will support the company in identifying investment opportunities and strategic collaborations within the expanding space economy, leveraging her industry network and experience spanning human spaceflight, research platforms and emerging commercial ventures. To view the full press release, visit https://ibn.fm/Xhn9y About Planet Ventures Inc. Planet Ventures Inc. is…

MondayMar 23, 2026 9:40 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Subsidiary Sapu Nano To Present Everolimus Toxicology Data At SOT 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its subsidiary Sapu Nano will present new data on everolimus toxicology at the Society of Toxicology 2026 Annual Meeting and ToxExpo in San Diego, highlighting findings on tissue concentration–driven effects and organ-specific outcomes beyond traditional plasma pharmacokinetics. The presentation underscores the importance of tissue-level drug distribution in determining toxicity profiles and supports the development of improved delivery strategies, including intravenous and nanoparticle-based formulations. To view the full press release, visit https://ibn.fm/kZzE3 About Sapu Nano Sapu Nano is a biotechnology company developing next-generation nanomedicine platforms to improve drug delivery, enhance therapeutic index, and unlock new clinical…

MondayMar 23, 2026 9:30 am

QualityStocksNewsBreaks – DitGold (CRYPTO: DITAU) Listed On Coinranking Expands Visibility Across Independent Crypto Data Platform

DitGold (CRYPTO: DITAU) is now listed on Coinranking, an independent cryptocurrency data platform known for its real-time pricing, exchange aggregation and user-focused design, providing increased visibility and access to market data across more than 300 exchanges. Coinranking emphasizes unbiased listings without paid placement, alongside fast, mobile-first functionality and millisecond-level data updates, positioning DitAu within a transparent market data environment as the project continues to build out its blockchain-based ecosystem focused on the tokenization and monetization of data assets. About DitGold DitGold is a blockchain-based project built on the Ethereum network that seeks to position data as a core economic asset…

Site Search

Company Search

Category: QualityStocksNewsBreaks